Clinical TCP data for prostate cancer indicate proton RBE declines modestly with rising dose per fraction yet stays near the nominal value of 1.1.
Stereotactic Body Radiotherapy for clinically localized prostate cancer: toxicity and biochemical disease-free outcomes from a multi-institutional patient registry
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
physics.med-ph 1years
2023 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response
Clinical TCP data for prostate cancer indicate proton RBE declines modestly with rising dose per fraction yet stays near the nominal value of 1.1.